Market Tracker

07/29 5:56am ET

Abbott Laboratories (NYSE:ABT)

44.45
Delayed Data
As of Jul 28
 +0.78 / +1.79%
Today’s Change
36.00
Today|||52-Week Range
51.24
-1.02%
Year-to-Date

Today’s Trading

Previous close43.67
Today’s open44.02
Day’s range43.93 - 45.16
Volume18,284,740
Average volume (3 months)9,869,731
Market cap$64.2B
Dividend yield2.34%
Data as of 07/28/2016

Growth & Valuation

Earnings growth (last year)+18.14%
Earnings growth (this year)+2.41%
Earnings growth (next 5 years)+10.05%
Revenue growth (last year)+0.78%
P/E ratio31.5
Price/Sales3.31
Price/Book3.03

Competitors

 Today’s
change
Today’s
% change
SHPGShire-3.01-1.55%
AZNAstraZeneca+2.75+8.72%
CELGCelgene+3.15+2.91%
REGNRegeneron Pharmaceut...-4.05-0.98%
Data as of 07/28/2016

Financials

Last reporting dateJuly 20, 2016
EPS forecast (this quarter)$0.53
Annual revenue (last year)$20.4B
Annual profit (last year)$2.7B
Net profit margin12.67%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Senior VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts